Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polyzois Makras

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 10, 2010
A case report of subacute thyroiditis during pregnancy: difficulties in differential diagnosis and changes in cytokine levelsAthanasios D Anastasilakis, Vassiliki Karanicola, Anargyros Kourtis, et al.
Hormones (Athens, Greece)|September 20, 2006
Langerhans' cell histiocytosis in an adult patient manifested as recurrent skull lesions and Diabetes InsipidusPolyzois Makras, Dimitris Papadogias, Chrysoula Samara, et al.
Bone|June 14, 2020
The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosisPolyzois Makras, Socrates E Papapoulos, Stergios A Polyzos, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 5, 2021
Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab DiscontinuationAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 28, 2017
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional CasesAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2019
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical TrialAthanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos, et al.
Pediatric Blood & Cancer|May 7, 2011
Reduced bone mineral density in adult patients with Langerhans cell histiocytosisPolyzois Makras, Evangelos Terpos, George Kanakis, et al.
Calcified Tissue International|February 10, 2011
No effect of rosuvastatin in the zoledronate-induced acute-phase responsePolyzois Makras, Athanasios D Anastasilakis, Stergios A Polyzos, et al.
Hormones (Athens, Greece)|June 3, 2025
Diagnosis and management of primary hyperparathyroidism: recommendations from the Bone Section of the Hellenic Endocrine SocietyAthanasios D Anastasilakis, Maria P Yavropoulou, Evanthia Kassi, et al.
Patient Preference and Adherence|January 17, 2023
Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in GreeceKyriakos Souliotis, Christina Golna, Christina Poimenidou, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 10, 2010
A case report of subacute thyroiditis during pregnancy: difficulties in differential diagnosis and changes in cytokine levelsAthanasios D Anastasilakis, Vassiliki Karanicola, Anargyros Kourtis, et al.
Hormones (Athens, Greece)|September 20, 2006
Langerhans' cell histiocytosis in an adult patient manifested as recurrent skull lesions and Diabetes InsipidusPolyzois Makras, Dimitris Papadogias, Chrysoula Samara, et al.
Bone|June 14, 2020
The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosisPolyzois Makras, Socrates E Papapoulos, Stergios A Polyzos, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 5, 2021
Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab DiscontinuationAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 28, 2017
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional CasesAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2019
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical TrialAthanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos, et al.
Pediatric Blood & Cancer|May 7, 2011
Reduced bone mineral density in adult patients with Langerhans cell histiocytosisPolyzois Makras, Evangelos Terpos, George Kanakis, et al.
Calcified Tissue International|February 10, 2011
No effect of rosuvastatin in the zoledronate-induced acute-phase responsePolyzois Makras, Athanasios D Anastasilakis, Stergios A Polyzos, et al.
Hormones (Athens, Greece)|June 3, 2025
Diagnosis and management of primary hyperparathyroidism: recommendations from the Bone Section of the Hellenic Endocrine SocietyAthanasios D Anastasilakis, Maria P Yavropoulou, Evanthia Kassi, et al.
Patient Preference and Adherence|January 17, 2023
Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in GreeceKyriakos Souliotis, Christina Golna, Christina Poimenidou, et al.
Pageof 13